Fingerprint
Dive into the research topics of 'Phase I and pharmacokinetic study of the oral farnesyltransferase inhibitor lonafarnib administered twice daily to pediatric patients with advanced central nervous system tumors using a modified continuous reassessment method: A pediatric brain tumor consortium study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically